Published in

Royal Society of Chemistry, RSC Medicinal Chemistry, 9(13), p. 1052-1057, 2022

DOI: 10.1039/d2md00154c

Links

Tools

Export citation

Search in Google Scholar

Fragment screening at AstraZeneca: developing the next generation biophysics fragment set

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The evolution of AstraZeneca's fragment screening library from multiple technology sets to a single, layered biophysics set.